Production (Stage)
LENZ Therapeutics, Inc.
LENZ
$31.96
$1.665.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.62M | -12.65M | -10.22M | -10.25M | -16.65M |
| Total Depreciation and Amortization | 36.00K | 25.00K | 10.00K | 18.00K | 5.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.50M | 222.00K | 832.00K | 638.00K | 1.72M |
| Change in Net Operating Assets | -2.97M | 3.33M | -1.21M | -6.20M | -9.01M |
| Cash from Operations | -16.05M | -9.08M | -10.58M | -15.80M | -23.94M |
| Capital Expenditure | -110.00K | -149.00K | -186.00K | -133.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.00M | -11.71M | -62.04M | -98.26M | 18.00M |
| Cash from Investing | 18.89M | -11.86M | -62.23M | -98.39M | 18.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 44.00K | 53.00K | 29.83M | -- | 53.82M |
| Repurchase of Common Stock | -- | -- | -- | -150.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -13.00K | -1.99M | 117.45M |
| Cash from Financing | 44.00K | 53.00K | 29.82M | -2.14M | 171.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.88M | -20.89M | -42.99M | -116.32M | 165.33M |